A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Moffitt Cancer Center, NewLink Genetics (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598118864
